|
|
||||||||
CLINICAL STUDY |
1 University Department of Growth and Reproduction GR, Rigshospitalet, University of Copenhagen, Section 5064, Blegdamsvej 9, DK-2100 Copenhagen Ø, Denmark and 2 Department of Biostatistics, University of Copenhagen, Copenhagen Ø, Denmark
(Correspondence should be addressed to L Aksglaede; Email: lise.aksglaede{at}rh.regionh.dk)
| Abstract |
|---|
|
|
|---|
Design: Cross-sectional study.
Methods: Ten KS infants aged 3.1 months (range 1.8–3.8) and 613 healthy controls aged 3.0 months (range 2.0–4.5). Serum levels of total and free testosterone (T), LH, FSH, inhibin B and sex hormone-binding globulin (SHBG) were determined.
Results: KS infants had significantly higher concentrations of total T (5.0 (2.2–11.2) vs 3.4 (0.7–8.3) nmol/l, P = 0.02), free T (31.6 (18.2–61.8) vs 22.1 (4.3–48.4) pmol/l, P = 0.01), LH (3.3 (1.3–4.6) vs 1.7 (0.6–4.3) IU/l, P = 0.005) and FSH (1.7 (1.1–4.1) vs 1.2 (0.4–3.0) IU/l, P = 0.007) than controls. SHBG and inhibin B did not differ from controls. LH/T and LH/free T ratios were normal, whereas the FSH/inhibin B ratio was elevated (6.5 (2.7–16.9) vs 3.0 (0.78–11.4), P = 0.005) when compared to controls. The majority of KS infants had normal bivariate hormonal combinations.
Conclusion: We found increased FSH/inhibin B ratio as a possible sign of Sertoli cell dysfunction. However, serum levels of T were high normal suggesting an altered pituitary–gonadal set point.
| Introduction |
|---|
|
|
|---|
It is well established that the hypothalamic–pituitary–gonadal (HPG) axis is transiently activated during the first months of postnatal life. In the healthy male infant gonadotrophins, sex steroids and inhibin B increase to pubertal or even adult levels at ~3 months of age, followed by a relatively quiescent period until reactivation of the HPG axis in puberty (2–6). The elevated inhibin B persists for a longer period of time than the elevated follicle-stimulating hormone (FSH), luteinizing hormone (LH) and testosterone (5, 7). The initial activation of the HPG axis is believed to be important for genital development, including renewal and differentiation of the germ cells. Furthermore, penile size (8) as well as postnatal testicular descent in cryptorchid boys (9) is influenced by sex steroids.
The postnatal surge of sex hormones represents a diagnostic window which enables the clinician to evaluate testicular function in infancy and to evaluate pituitary–testicular function in patients with congenital hypogonadotrophic hypogonadism (6, 10) as well as congenital adrenal hypoplasia (11), androgen insensitivity (12), Prader–Willi (13) and KS (14, 15).
To our knowledge, two studies have evaluated infant reproductive hormone levels in KS (14, 15). In both of these studies, it was shown that the testicular hormonal surge generated during the first months of postnatal life was compromised, with reduced testosterone (T) concentrations but normal serum levels of inhibin B (14), LH and FSH, suggesting some degree of primary testicular failure already present in the infancy period.
The aim of the present study was therefore to evaluate if primary testicular failure in KS is already present in early infancy.
| Subjects and methods |
|---|
|
|
|---|
Ten boys with non-mosaic 47,XXY KS were investigated at the age of 3.1 months (range 1.8–3.8). The syndrome was diagnosed prenatally by amniocentesis as part of a screening programme and should therefore constitute an unbiased cohort with no selection through clinical symptoms. Diagnosis was confirmed by postnatal karyotyping. All boys had spontaneously descended testes at birth. Clinical data on the KS infants were obtained from patient records for this study.
The controls constituted 613 healthy boys aged 3.0 months (range 2.0–4.5) who participated in a prospective cohort study performed from 1997 to 2001 at the University Hospitals in Copenhagen, Denmark (Rigshospitalet and Hvidovre Hospital) (16). In this study, only boys with no signs of cryptorchidism, hypospadias or foreskin malformations were included.
Ethics
The study was performed according to the Helsinki II declaration and was approved by the local ethics committee ((KF) 01-030/97). Parents gave written informed consent. Registration of clinical data was approved by the Danish Data Protection Agency (1997-1200-074) and (2005-41-5479).
Hormonal assays
Blood samples were drawn from an antecubital vein at a median time of 1120 h (1040–1700 h) in the Klinefelter boys and at a median time of 1200 h (0900–1600 h) in the control group. Blood was clotted, centrifuged, and serum was stored at –20 °C until hormone analyses were performed. FSH and LH were measured by two-sided time-resolved immunofluorometric assays (Delfia; Wallac, Turku, Finland) with detection limits of 0.05 IU/l and intra- and inter-assay coefficients of variation (CV) of <3 and <5% respectively.
Serum inhibin B was measured by a specific ELISA (Oxford Bio Innovation, Oxford, UK) with detection limit of 20 pg/ml. Intra- and inter-assay CVs were <13 and 19% respectively.
Sex hormone-binding globulin (SHBG) was determined by a time-resolved fluoroimmunoassay (Delfia; Wallac) with a detection limit of 0.23 nmol/l and intra- and inter-assay CVs of <5%.
Testosterone was measured by a solid-phase RIA (Coat-a-count; Diagnostic Products Corp., Los Angeles, CA, USA) without previous extraction. The detection limit was 0.23 nmol/l, and the intra- and inter-assay CVs were <10% at the highest levels and 17% at the lowest levels found.
Free testosterone (free T) was calculated using the equation of Vermeulen (17) and an assumed fixed albumin concentration. This assumption is based on the fact that changes in albumin have only minute effects on the calculated free T, and that it is reasonable not to measure individual albumin levels when abnormality is not suspected. We applied a fixed albumin concentration of 40 g/l in accordance with the age of the individuals (18).
FSH and LH levels were available in all KS infants, but inhibin B levels were only available in seven KS infants, and the free T concentration was only calculated in eight KS infants due to lack of SHBG measurements in two infants. In the control infants, hormone determinations were available in 609 (T), 602 (free T), 588 (LH), 591 (FSH), 607 (SHBG) and 578 (inhibin B) boys respectively.
Clinical evaluation
Body length was measured with a portable infantometer (Kiddimeter; Raven Equipment, Essex, UK) to the nearest 0.1 cm. Body weight was measured on a digital scale to the nearest 0.005 kg. Height was available in 543 controls, whereas weight was available in 577 controls. Testicular volume was evaluated by standard orchidometer measurements in the KS infants, but not the controls.
Statistical analysis
Biochemical characteristics are provided as medians, 2.5 and 97.5 percentiles, if not otherwise indicated.
Bivariate reference charts of total and free T in conjunction with the corresponding LH and inhibin B with corresponding FSH were constructed based on the control subjects as previously described (19–21). The bivariate reference represents a curve, beyond which a paired measurement of, for example, T and LH in an individual will be considered abnormal. These curves separate the individuals with an abnormal LH–T combination (or LH-free T or inhibin B–FSH) from the individuals with a normal combination. At the same time, one can read the 2.5 and 97.5 percentiles of the involved hormones as the horizontal and vertical lines respectively, of the curve. Thus, individuals outside the reference curve may have elevated serum levels of LH or FSH and/or decreased serum levels of testosterone or inhibin B, depending on the reference chart chosen.
The Mann–Whitney U test was used to test for differences in hormone levels between KS infants and controls. A P value of <0.05 was considered statistically significant.
| Results |
|---|
|
|
|---|
Birth weight and clinical characteristics at the examination are presented in Table 1
. There was no difference between birth weights between KS and controls, but KS infants were significantly lighter and shorter than controls at the time of examination. Testicular volume was smaller (1.0 ml (0.5–2.0)) than previously reported by Cassorla et al (22) in healthy boys at 3 months of age (mean volume of left testicle 2.05 ml (±0.15 S.E.M.) and right testicle 1.95 ml (±0.11 S.E.M.)).
|
Basal serum levels of total T, free T, LH, FSH, SHBG and inhibin B in the KS infants according to age are shown in comparison with the levels of healthy control infants (Fig. 1A–F
).
|
|
| Discussion |
|---|
|
|
|---|
The results of our study are in contrast with previously reported data on KS infants in which the levels of T compared to a control group were decreased, but LH, FSH and inhibin B (14) levels were reported to be normal (14, 15). However, when we compare the T levels of the 12 KS boys <6 months of age in the study of Ross and co-workers (15) with the levels in our 613 healthy infants (15), we found no differences. It was not possible to carry out such a comparison with the KS boys in the study of Lahlou et al. (14) as no individual concentrations were given. The same normative data for reproductive hormone levels in healthy infant boys (examined due to non-endocrine and non-metabolic reasons) were used in these two studies. This could be due to differences in hormone levels according to different assay platforms (23). Nevertheless, the reported levels of T in the control infants in the two KS studies were much higher (4–20 nmol/l (5th–95th percentiles); (14, 15)) than reported by any other study (2, 3, 5, 24–28), including this study.
Our study provides new data on the relationship between total T (and free T) and the corresponding LH values and between inhibin B and the corresponding FSH in 3-month-old infants. These bivariate evaluations of two related markers are valuable tools in adult andrological medicine (21). The two-dimensional reference charts visually describe the status of the pituitary–Leydig cell axis and the pituitary–Sertoli cell axis in normal infants by separating the individuals with an abnormal LH–T combination (or LH-free T or inhibin B–FSH) from the individuals with a normal combination.
In the bivariate LH–T evaluation, the majority of KS infants were inside the reference range although the levels were skewed. Concomitantly, high LH and T levels suggested an alteration in the pituitary–Leydig cell set point.
Our finding of increased FSH/inhibin B ratio suggests that a subtle Sertoli cell dysfunction might already be manifest at this early stage. Theoretically, increased gonadotrophin-releasing hormone drive due to the impaired Sertoli cell function may not only result in increased FSH but also increased the LH. However, inhibin B levels were only available in seven out of ten Klinefelter infants, and this statement needs further studies to be clarified.
The hormonal surge is known to arise during the first months of life and the diagnostic window is quite narrow, around 3 months of age. Our controls were examined between 2.0 and 4.5 months of age, whereas the Klinefelter boys were aged 1.8–3.8 months at examination. Although there was no difference between mean ages in the two groups, it can be speculated that the older controls bias the results. However, limiting the comparison to the controls of an age between 2.0 and 3.8 months did not alter any results (data not shown).
The incidence of cryptorchidism was recently found to be 6.25% higher in KS than in healthy controls (29). Diagnosis of KS was completed prenatally and our cohort of Klinefelter infants should therefore constitute an unbiased cohort. However, the present Klinefelter infants may not represent the broad phenotypic spectrum of KS usually followed in a paediatric endocrine clinic as none were born with cryptorchidism.
In a recent longitudinal study during puberty in KS, no signs of hypogonadism were evident until mid-puberty (30). These Klinefelter boys entered puberty at the expected age with increasing T secretion and showed normal changes in indices of androgen action (i.e. serum SHBG, leptin and prostate-specific antigen) (30). In that study, T secretion remained normal throughout puberty, whereas gonadotrophins increased to supranormal levels around mid-puberty. Thus, these boys seem to enter a stage of compensated hypoandrogenism after an apparently normal initiation of puberty.
Testosterone substitution is widely used in adults with KS, but it is unknown at present if early initiation of androgen replacement therapy at the onset of puberty would prevent symptoms of hypogonadism, i.e. osteoporosis, the metabolic syndrome, etc. Recently, androgen treatment in KS boys already in the infancy period has been suggested and case reports of such treatment exist (14). Future controlled studies on possible beneficial effects of T replacement in KS infants remain to be seen. However, our finding of normal (or even high normal) T in KS infants does not support routine androgen treatment in infancy of all KS infants.
In conclusion, our study of ten infants with KS provides evidence of a subtle Sertoli cell dysfunction with low normal inhibin B levels, but high normal levels of T and increased LH at this early age. We found no biochemical support for early hypoandrogenism, as has been reported previously.
| Acknowledgements |
|---|
| References |
|---|
|
|
|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |